Peg Horn

Peg Horn

Direttore operativo presso REVOLUTION MEDICINES, INC.

Patrimonio netto: 24 M $ in data 31/05/2026

63 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Margaret A. Horn is currently an Independent Director at Sangamo Therapeutics, Inc. since 2022.
She serves as Secretary & General Counsel at Genencor International, Inc. since 1991.
She is a Member of The State Bar of California and the Pennsylvania State Bar Association.
She is Chief Operating Officer at Revolution Medicines, Inc. since 2018.
Formerly, Ms. Horn was General Counsel & Secretary at Kosan Biosciences, Inc. from 2005 to 2007.
She was SVP-Corporate Development & General Counsel at Cogentus Pharmaceuticals, Inc. in 2009.
She worked as Principal at E.I.
du Pont de Nemours & Co. She was Chief Operating Officer at Prolynx LLC from 2010 to 2014.
Education includes undergraduate studies at the University of the Sciences in Philadelphia, graduate studies at Charles Widger School of Law, and an MBA from The Pennsylvania State University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
17/06/2026 154.647 ( 0,07% ) 24 M $ 31/05/2026
12/06/2025 82.650 ( 0,02% ) 18 018 $ 31/05/2026

Posizioni attive di Peg Horn

SocietàPosizioneInizio
REVOLUTION MEDICINES, INC. Direttore operativo 01/10/2018
SANGAMO THERAPEUTICS, INC. Direttore/Membro del Consiglio 15/12/2022
Consigliere Generale 01/01/1991
Corporate Officer/Principal -
Corporate Officer/Principal -

Precedenti posizioni note di Peg Horn

SocietàPosizioneFine
Direttore operativo 01/12/2014
Consigliere Generale 18/12/2009
Corporate Officer/Principal -
Consigliere Generale 24/08/2007
Vedi nel dettaglio l'esperienza di Peg Horn

Formazione di Peg Horn

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

81

Relazioni di 1° grado

12

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private12

Health Technology

Health Technology

Health Technology

Health Technology

Process Industries

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Commercial Services

Consumer Services

-40%: Proroga eccezionale
g
:
:
ENTRA ORA